Welcome to the biotech age

Now the human genome has been mapped, we are at the dawn of a brave new biotech age. But can the private sector now get involved please?
June 27, 2000

With the news of the successful mapping of the human genome, we can truly say that we have entered the biotech age. But what is biotech? Biotechnology is the development and manipulation of genetic material to produce improved products such as insect resistant crops or synthetic blood. It has applications in industry, medicine and agriculture.

Sign in to read on!

Registered users get 2 free articles in 30 days.

Subscribers have full unlimited access to FinanceAsia.

Not signed up? New users get 2 free articles per month, plus a 7-day unlimited free trial.

Questions?
See here for more information on licences and prices, or contact [email protected].

Related Articles

HKEX eyes more global biotechs to build IPO hub

Amid a structural shift towards Asia, Insilico Medicine's IPO in December was a significant moment for the exchange, while French biotech TheraVectys is understood to be considering a listing.
February 24, 2026

Marex takes stake in NZ's Ruminant Biotech

Ruminant Biotech, a New Zealand-based tech business looking to reduce methane emissions from pasture-based livestock, has raised around $9.5m in a Series A fundraising.
November 26, 2025

Biotech firms switch listings from Nasdaq to HKEX

Hong Kong-listed biotech firms are outperforming as Trump’s policies cause firms to change course from their traditional US destination, with more HKEX listings expected in the second half of 2025; experts shared their views at BIOHK.
September 23, 2025